All 132 BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Holdings
There are 132 BBC holdings. Top 10 companies weight: 10.66%.
Total Market Cap: $312B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (132 stocks) | +12.97% | 8.31 | 4.33 | 0.25 | +59.48% | +10.00% | 1.25 | ||||||||||
51 | ORKA | Oruka Therapeutics Inc | 0.78% | $94.32 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +53.38% | $145 | +32.89% | N/A |
52 | AMLX | Amylyx Pharmaceuticals Inc | 0.77% | $18.50 | $1.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +33.51% | $25 | 0.00% | 1.14 |
53 | CGON | Cg Oncology Inc | 0.77% | $71.72 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +25.89% | $90 | 0.00% | 1.46 |
54 | CLDX | Celldex Therapeutics Inc | 0.77% | $35.66 | $2.55B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +63.21% | $58 | -4.26% | 1.17 |
55 | SRRK | Scholar Rock Holding Corp | 0.77% | $50.88 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +16.57% | $59 | +9.01% | 0.67 |
56 | MAZE | Maze Therapeutics Inc | 0.77% | $29.30 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +113.48% | $63 | 0.00% | 0.87 |
57 | XNCR | Xencor Inc | 0.77% | $20.45 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +38.53% | $28 | -8.77% | 1.43 |
58 | DNTH | Dianthus Therapeutics Inc | 0.77% | $105.72 | $5.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +21.62% | $129 | 0.00% | 1.12 |
59 | CTMX | Cytomx Therapeutics Inc | 0.77% | $3.42 | $652M | Biotechnology | Healthcare | N/A | 24.82 | 14.20 | 0.76 | N/A | N/A | 83 | +265.50% | $13 | -9.49% | 2.01 |
60 | RVMD | Revolution Medicines Inc Ordinary Shares | 0.76% | $183.29 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +9.41% | $201 | +44.92% | 1.09 |
61 | TYRA | Tyra Biosciences Inc | 0.76% | $31.85 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +63.17% | $52 | 0.00% | 1.02 |
62 | CLYM | Climb Bio Inc | 0.76% | $13.10 | $663M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +59.77% | $21 | 0.00% | 1.37 |
63 | OCS | Oculis Holding Ag | 0.75% | $11.96 | $773M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +212.88% | $37 | 0.00% | 0.66 |
64 | PCVX | Vaxcyte Inc Ordinary Shares | 0.75% | $58.04 | $8.19B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +87.80% | $109 | +20.85% | 0.73 |
65 | ALMS | Alumis Inc | 0.75% | $30.05 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +33.44% | $40 | 0.00% | 0.88 |
66 | AKTS | Aktis Oncology Inc | 0.75% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
67 | IMVT | Immunovant Inc | 0.75% | $39.53 | $8.13B | Biotechnology | Healthcare | +18.52% | N/A | N/A | N/A | N/A | N/A | 70 | +19.38% | $47 | +31.25% | 1.21 |
68 | COGT | Cogent Biosciences Inc | 0.75% | $39.64 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +36.86% | $54 | +42.82% | 1.71 |
69 | OLMA | N/A | 0.75% | $11.59 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +251.16% | $41 | -14.19% | 0.72 |
70 | PRAX | N/A | 0.75% | $317.87 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +91.92% | $610 | +4.14% | 0.93 |
71 | UPB | Upstream Bio Inc | 0.75% | $6.98 | $396M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +447.99% | $38 | 0.00% | 1.09 |
72 | RZLT | Rezolute Inc | 0.75% | $5.09 | $456M | Biotechnology | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 70 | +50.69% | $7.67 | -13.48% | 0.96 |
73 | EWTX | Edgewise Therapeutics Inc | 0.74% | $39.58 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +26.12% | $50 | +14.06% | 1.37 |
74 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.74% | $16.26 | $976M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +128.72% | $37 | -11.75% | 1.20 |
75 | RCUS | Arcus Biosciences Inc | 0.74% | $29.48 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +21.27% | $36 | -2.24% | 1.50 |
76 | MLYS | Mineralys Therapeutics Inc | 0.73% | $27.52 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +78.05% | $49 | 0.00% | 0.77 |
77 | ASMB | Assembly Biosciences Inc | 0.73% | $26.47 | $425M | Biotechnology | Healthcare | -44.47% | N/A | 15.24 | N/A | N/A | N/A | 75 | +88.89% | $50 | -9.18% | 1.03 |
78 | VRDN | Viridian Therapeutics Inc | 0.73% | $19.18 | $1.95B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 79 | +88.32% | $36 | +2.18% | 1.09 |
79 | GPCR | Structure Therapeutics Inc Adr | 0.73% | $49.35 | $3.53B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +111.94% | $105 | 0.00% | 0.83 |
80 | ELVN | Enliven Therapeutics Inc | 0.73% | $54.33 | $3.24B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +21.48% | $66 | +19.34% | 1.17 |
81 | GENB | Generate Biomedicines Inc | 0.72% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
82 | ACHV | Achieve Life Sciences Inc | 0.72% | $6.50 | $174M | Biotechnology | Healthcare | -20.82% | N/A | 35.34 | N/A | N/A | N/A | 80 | +112.31% | $14 | -3.43% | N/A |
83 | LXRX | Lexicon Pharmaceuticals Inc | 0.72% | $2.38 | $937M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +58.40% | $3.77 | -7.69% | 1.08 |
84 | PHVS | Pharvaris Nv Ordinary Shares | 0.72% | $34.45 | $2.30B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +37.10% | $47 | +18.99% | 0.66 |
85 | NKTR | Nektar Therapeutics | 0.72% | $68.67 | $1.69B | Biotechnology | Healthcare | -24.01% | N/A | 34.01 | 0.31 | N/A | N/A | 75 | +123.17% | $153 | -22.51% | 1.82 |
86 | ALT | Altimmune Inc | 0.72% | $2.82 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +447.87% | $15 | -21.15% | 1.53 |
87 | LBRX | Lb Pharmaceuticals Inc | 0.71% | $32.31 | $922M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +39.28% | $45 | 0.00% | 0.60 |
88 | CADL | Candel Therapeutics Inc | 0.71% | $10.22 | $706M | Biotechnology | Healthcare | N/A | N/A | 43.48 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
89 | SGP | Spyglass Pharma Inc | 0.70% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
90 | VIR | Vir Biotechnology Inc | 0.70% | $9.42 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +128.87% | $22 | -24.08% | 1.52 |
91 | SVRA | Savara Inc | 0.70% | $5.84 | $1.19B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +87.33% | $11 | +33.84% | 1.22 |
92 | IRON | Disc Medicine Inc Ordinary Shares | 0.70% | $75.58 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +34.36% | $102 | +8.36% | 1.15 |
93 | CMPS | Compass Pathways Plc Adr | 0.69% | $12.18 | $1.80B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +100.90% | $24 | -19.88% | 1.38 |
94 | REPL | Replimune Group Inc | 0.69% | $11 | $801M | Biotechnology | Healthcare | +16.21% | N/A | N/A | N/A | N/A | N/A | 56 | -3.00% | $11 | -19.74% | 0.74 |
95 | AURA | Aura Biosciences Inc | 0.69% | $7.03 | $430M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +167.43% | $19 | 0.00% | 1.11 |
96 | ARVN | Arvinas Inc | 0.69% | $8.26 | $534M | Biotechnology | Healthcare | +1.07% | N/A | 17.86 | N/A | N/A | N/A | N/A | N/A | N/A | -37.19% | N/A |
97 | BLTE | Belite Bio Inc Adr | 0.68% | $161.08 | $5.88B | Biotechnology | Healthcare | +24.69% | N/A | 227.27 | N/A | N/A | N/A | 81 | +30.68% | $211 | 0.00% | 0.56 |
98 | BBOT | Bridgebio Oncology Therapeutics Inc | 0.68% | $8.72 | $674M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +190.14% | $25 | 0.00% | 1.26 |
99 | AVBP | Arrivent Biopharma Inc | 0.68% | $28.26 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
100 | NTLA | Intellia Therapeutics Inc | 0.68% | $11.47 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +128.16% | $26 | -40.03% | 1.78 |
BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Sector Allocation
HEALTHCARE
90.20%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%